Company Overview of Sonexa Therapeutics, Inc.
Sonexa Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops drug treatments and therapeutics for the Alzheimer's disease and related disorders. The company develops ST101, a small and orally active molecule compound that penetrates the blood-brain-barrier and restores learning and memory capability across an array of animal models of cognitive impairment relevant to Alzheimer's. The company was incorporated in 2007 and is based in San Diego, California.
12481 High Bluff Drive
San Diego, CA 92130
Founded in 2007
Key Executives for Sonexa Therapeutics, Inc.
Sonexa Therapeutics, Inc. does not have any Key Executives recorded.
Similar Private Companies By Industry
|21st Century Animal Health||United States|
|3 Buds' Organics LLC||United States|
|4P Therapeutics LLC||United States|
|60° Pharmaceuticals, LLC||United States|
|7 Oaks Pharmaceutical Corp.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|Bloomberg L.P.||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
To contact Sonexa Therapeutics, Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.